From what I recall Steven stating, we will be seeking FDA approval which the TGA here recognise (but still requires a signature by the TGA to run trials here or export drugs to the US for trials there from what i have read).
Whilst OmniCAR requires IND (Investigational New Drug) approval, we only require one... regardless of the number of antigens being targeted.
